Situation of ischemic stroke-related residual dysfunction in patients and its influencing factors in community

doi:10.3969/j.issn.1004-583X.2021.12.003

Abstract

Abstract:

Objective To survey the situation of residual dysfunction of ischemic stroke (IS) in patients and its influencing factors in community. Methods This study included IS patients who admitted to the community health service centers in Shijiazhuang City ( Taoyuan Community, Yuqiang Community, Dongyuan Community) from May to September 2020. A questionnaire focusing on those target population were performed which supplied by the platform named “Wenjuanxing”. The general address data and stroke-related data was collected by general practitioners in the community, and to screen influencing factors for stroke-related residual dysfunction. Results There are 122 males (52.6%) and 110 females (47.4%) in out of involved 232 IS patients, of which 99 patients (42.7%) had sequelae. Multivariate logistic regression analysis suggested that the main influencing factors for stroke-related residual dysfunction were whether dyslipidemia, coronary heart disease, long-term mental stress, regular exercise, recurrence of stroke, and glucose stability (P<0.05). Conclusion For IS patients, the influencing factors for stroke-related residual dysfunction are dyslipidemia, coronary heart disease, long-term mental stress, recurrence of stroke; Protective factors for those was regular exercise and glucose stability. Proper diet, aerobic exercise and drug intervention is capable controlling patient's glycemia, blood lipids and weight in the normal range, which has positive significance in preventing and reducing stroke-related residual dysfunction.

Key words: ischemic stroke, sequelae, cross-sectional studies, risk factors

CLC Number:

R743.3

Zhang Qin, Wang Shubin, Su Xuan, Yuan Rui, Gao Mengxi, Guo Liru. Situation of ischemic stroke-related residual dysfunction in patients and its influencing factors in community[J]. Clinical Focus, 2021, 36(12): 1073-1078.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2021.12.003

https://huicui.hebmu.edu.cn/EN/Y2021/V36/I12/1073

Figures/Tables 2

项目	例数	脑卒中后遗症	χ²值	$P$ 值
高血压
有无	134 95	62(46.3) 35(36.8)	1.655	0.198
糖尿病
有无	66 163	35(53.0) 62(38.0)	3.733	0.053
血脂异常
有无	93 136	52(55.9) 45(33.1)	10.870	0.001
冠心病
有无	41 188	25(61.0) 72(38.3)	6.191	0.013
抗血小板药物
有无	107 122	49(45.8) 49(40.2)	0.526	0.468
抗凝药物
有无	26 203	18(69.2) 80(39.4)	7.199	0.007
降压药物
有无	134 95	67(50.0) 31(32.6)	6.159	0.013
降脂药物
有无	108 121	57(52.8) 41(33.9)	7.567	0.006
脑卒中复发
有无	81 147	57(70.4) 40(27.2)	38.051	0.000
脑血管病家族史
有无	66 161	31(47.0) 66(41.0)	0.461	0.497
冠心病家族史
有无	49 178	30(61.2) 67(37.6)	7.796	0.005
吸烟史
有无	48 184	29(60.4) 70(38.0)	6.902	0.009
饮酒史
有无	67 165	35(52.2) 64(38.8.)	2.996	0.083
长期精神紧张
有无	36 195	23(63.9) 75(38.5)	7.037	0.008
性格易激动
有无	46 185	26(56.5) 72(38.9)	3.980	0.046
爱吃高油高盐食物
有无	58 173	28(48.3) 70(40.5)	0.789	0.374
体力活动不足
有无	53 178	28(52.8) 70(39.3)	2.521	0.112
规律运动
有无	67 160	22(32.8) 76(47.5)	3.563	0.059
血糖水平
稳定不稳定	113 96	35(31.0) 52(54.2)	10.556	0.001

项目	例数	脑卒中后遗症	χ²值	$P$ 值
高血压
有无	134 95	62(46.3) 35(36.8)	1.655	0.198
糖尿病
有无	66 163	35(53.0) 62(38.0)	3.733	0.053
血脂异常
有无	93 136	52(55.9) 45(33.1)	10.870	0.001
冠心病
有无	41 188	25(61.0) 72(38.3)	6.191	0.013
抗血小板药物
有无	107 122	49(45.8) 49(40.2)	0.526	0.468
抗凝药物
有无	26 203	18(69.2) 80(39.4)	7.199	0.007
降压药物
有无	134 95	67(50.0) 31(32.6)	6.159	0.013
降脂药物
有无	108 121	57(52.8) 41(33.9)	7.567	0.006
脑卒中复发
有无	81 147	57(70.4) 40(27.2)	38.051	0.000
脑血管病家族史
有无	66 161	31(47.0) 66(41.0)	0.461	0.497
冠心病家族史
有无	49 178	30(61.2) 67(37.6)	7.796	0.005
吸烟史
有无	48 184	29(60.4) 70(38.0)	6.902	0.009
饮酒史
有无	67 165	35(52.2) 64(38.8.)	2.996	0.083
长期精神紧张
有无	36 195	23(63.9) 75(38.5)	7.037	0.008
性格易激动
有无	46 185	26(56.5) 72(38.9)	3.980	0.046
爱吃高油高盐食物
有无	58 173	28(48.3) 70(40.5)	0.789	0.374
体力活动不足
有无	53 178	28(52.8) 70(39.3)	2.521	0.112
规律运动
有无	67 160	22(32.8) 76(47.5)	3.563	0.059
血糖水平
稳定不稳定	113 96	35(31.0) 52(54.2)	10.556	0.001

变量(赋值)	回归系数	标准误	Wald χ²值	$P$ 值	$OR$ 值	95% $CI$
变量(赋值)	回归系数	标准误	Wald χ²值	$P$ 值	$OR$ 值	下限	上限
糖尿病(1)	0.354	0.392	0.813	0.367	1.424	0.660	3.072
血脂异常(1)	0.944	0.431	4.786	0.029	2.569	1.103	5.984
冠心病(1)	1.21	0.477	6.427	0.011	3.352	1.316	8.540
服用抗凝药物(1)	0.648	0.567	1.306	0.253	1.912	0.629	5.815
服用降压药物(1)	0.523	0.344	2.313	0.128	1.687	0.860	3.310
服用降血脂药物(1)	-0.008	0.428	0.000	0.985	0.992	0.428	2.297
吸烟史(1)	0.356	0.405	0.772	0.38	1.428	0.645	3.159
长期精神紧张(1)	1.124	0.477	5.541	0.019	3.077	1.207	7.843
血糖水平稳定(1)	-0.832	0.359	5.38	0.02	0.435	0.215	0.879
规律运动(1)	-0.792	0.368	4.622	0.032	0.453	0.220	0.932
脑卒中复发(1)	0.354	0.392	0.813	0.367	1.424	0.660	3.072

变量(赋值)	回归系数	标准误	Wald χ²值	$P$ 值	$OR$ 值	95% $CI$
变量(赋值)	回归系数	标准误	Wald χ²值	$P$ 值	$OR$ 值	下限	上限
糖尿病(1)	0.354	0.392	0.813	0.367	1.424	0.660	3.072
血脂异常(1)	0.944	0.431	4.786	0.029	2.569	1.103	5.984
冠心病(1)	1.21	0.477	6.427	0.011	3.352	1.316	8.540
服用抗凝药物(1)	0.648	0.567	1.306	0.253	1.912	0.629	5.815
服用降压药物(1)	0.523	0.344	2.313	0.128	1.687	0.860	3.310
服用降血脂药物(1)	-0.008	0.428	0.000	0.985	0.992	0.428	2.297
吸烟史(1)	0.356	0.405	0.772	0.38	1.428	0.645	3.159
长期精神紧张(1)	1.124	0.477	5.541	0.019	3.077	1.207	7.843
血糖水平稳定(1)	-0.832	0.359	5.38	0.02	0.435	0.215	0.879
规律运动(1)	-0.792	0.368	4.622	0.032	0.453	0.220	0.932
脑卒中复发(1)	0.354	0.392	0.813	0.367	1.424	0.660	3.072

References 26

[1]	Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: A systematic analysis for the Global Burden of Disease Stud[J]. Lancet, 2019, 394(10204):1145-1158. doi: 10.1016/S0140-6736(19)30427-1 URL
[2]	纪树荣. 康复医学[M]. 北京: 高等教育出版社, 2014: 165.
[3]	Skolarus LE, Burke JF, Brown DL, et al. Understanding stroke survivorship: Expanding the concept of poststroke disability[J]. Stroke, 2014, 45(1):224-230. doi: 10.1161/STROKEAHA.113.002874 pmid: 24281223
[4]	Jonsson AC, Delavaran H, Lovkvist H, et al. Secondary prevention and lifestyle indices after stroke in a long-term perspective[J]. Acta Neurol Scand, 2018, 138(3):227-234. doi: 10.1111/ane.2018.138.issue-3 URL
[5]	倪金迪, 李响, 刘梅, 等. 脑卒中及短暂性脑缺血发作的二级预防指南核心内容(2014年AHA/ASA版)[J]. 中国临床神经科学, 2015, 23(1):65-73.
[6]	Goljar N, Burger H, Vidmar G, et al. Functioning and disability in stroke[J]. Disabil Rehabil, 2010, 32(Suppl 1):S50-58. doi: 10.3109/09638288.2010.517598 URL
[7]	黄如训, 郭玉璞. 2000年广州全国脑血管病专题研讨会脑卒中的分型分期治疗(建议草案)[J]. 中国神经精神疾病杂志, 2001, 15(9):592-594.
[8]	Luengo-Fernandez R, Paul NL, Gray AM, et al. Population-based study of disability and institutionalization after transient ischemic attack and stroke: 10-year results of the Oxford Vascular Study[J]. Stroke, 2013, 44(10):2854-2861. doi: 10.1161/STROKEAHA.113.001584 pmid: 23920019
[9]	Hackett M, Duncan J, Anderson C, et al. Health-related quality of life among long-term survivors of stroke: Results from the Auckland Stroke Study, 1991-1992[J]. Stroke, 2000, 31(2):440-447. pmid: 10657420
[10]	Phan TG, Demchuk A, Srikanth V, et al. Proof of concept study: Relating infarct location to stroke disability in the NINDS rt-PA trial[J]. Cerebrovasc Dis, 2013, 35(6):560-565. doi: 10.1159/000351147 URL
[11]	Wu O, Cloonan L, Mocking SJ, et al. Role of acute lesion topography in initial ischemic stroke severity and long-term functional outcomes[J]. Stroke, 2015, 46(9):2438-2444. doi: 10.1161/STROKEAHA.115.009643 URL
[12]	Laufer Y, Sivan D, Schwarzmann R, et al. Standing balance and functional recovery of patients with right and left hemiparesis in the early stages of rehabilitation[J]. Neurorehabil Neural Repair, 2003, 17(4):207-213. doi: 10.1177/0888439003259169 URL
[13]	Ween JE, Alexander MP, D’Esposito M, et al. Factors predictive of stroke outcome in a rehabilitation setting[J]. Neurology, 1996, 47(2):388-392. pmid: 8757009
[14]	王珵, 陶汉川, 姜小兰, 等. 缺血性脑卒中后认知功能障碍与梗死部位及体积的关系分析[J]. 吉林医学, 2021, 42(7):1626-1631.
[15]	王班, 关天嘉, 尤莉莉, 等. 我国缺血性脑卒中残疾情况及其影响因素分析[J]. 中国全科医学, 2016, 19(2):216-219.
[16]	Bailey RR, Serra MC, Mcgrath RP. Obesity and diabetes are jointly associated with functional disability in stroke survivors[J]. Disabil Health J, 2020, 13(3):100914. doi: S1936-6574(20)30038-8 pmid: 32139319
[17]	Pikija S, Trkulja V, Juvan L, et al. Higher on-admission serum triglycerides predict less severe disability and lower all-cause mortality after acute ischemic stroke[J]. J Stroke Cerebrovasc Dis, 2013, 22(7):e15-e24. doi: 10.1016/j.jstrokecerebrovasdis.2012.03.006 URL
[18]	Heron N, O'Connor SR, Kee F, et al. Usability and acceptability of a novel secondary prevention initiative targeting physical activity for individuals after a transient ischaemic attack or "minor" stroke: A qualitative study[J]. Int J Environ Res Public Health, 2020, 17(23):8788. doi: 10.3390/ijerph17238788 URL
[19]	Billinger SA, Arena R, Bernhardt J, et al. Physical activity and exercise recommendations for stroke survivors: A statement for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2014, 45(8):2532-2553. doi: 10.1161/STR.0000000000000022 pmid: 24846875
[20]	Gothe NP, Bourbeau K. Associations between physical activity intensities and physical function in stroke survivors[J]. Am J Phys Med Rehabil, 2020, 99(8):733-738. doi: 10.1097/PHM.0000000000001410 URL
[21]	Fekete K, Szátmari S, Szócs J, et al. Prestroke alcohol consumption and smoking are not associated with stroke severity, disability at discharge, and case fatality[J]. J Stroke Cerebrovasc Dis, 2013, 23(1):e31-e37. doi: 10.1016/j.jstrokecerebrovasdis.2013.08.006 URL
[22]	Wang HK, Huang CY, Sun YT, et al. Smoking paradox in stroke survivors?: Uncovering the truth by interpreting 2 sets of data[J]. Stroke, 2020, 51(4):1248-1256. doi: 10.1161/STROKEAHA.119.027012 URL
[23]	van de Weg FB, Kuik DJ, Lankhorst GJ. Post-stroke depression and functional outcome: A cohort study investigating the influence of depression on functional recovery from stroke[J]. Clin Rehabil, 1999, 13(3):268-272. pmid: 10392654
[24]	Shi YZ, Xiang YT, Yang Y, et al. Depression after minor stroke: The association with disability and quality of life--a 1-year follow-up study[J]. Int J Geriatr Psychiatry, 2016, 31(4):421-427. doi: 10.1002/gps.v31.4 URL
[25]	El Husseini N, Goldstein LB, Peterson ED, et al. Depression status is associated with functional decline over 1-year following acute stroke[J]. J Stroke Cerebrovasc Dis, 2017, 26(7):1393-1399. doi: S1052-3057(17)30131-3 pmid: 28389192
[26]	Park JH, Ovbiagele B. Relationship of functional disability after a recent stroke with recurrent stroke risk[J]. Eur J Neurol, 2016, 23(2):361-367. doi: 10.1111/ene.12837 pmid: 26493027